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ABSTRACT
Neuronal ceroid lipofuscinosis (NCL) is the most common childhood-
onset neurodegenerative disease. NCL is inevitably fatal, and there
is currently no treatment available. Children with NCL show a
progressive decline in movement, vision and mental abilities, and an
accumulation of autofluorescent deposits in neurons and other cell
types. Late-infantile NCL is caused by mutations in the lysosomal
protease tripeptidyl peptidase 1 (TPP1). TPP1 cleaves tripeptides
from the N-terminus of proteins in vitro, but little is known about the
physiological function of TPP1. TPP1 shows wide conservation in
vertebrates but it is not found in Drosophila, Caenorhabditis elegans
or Saccharomyces cerevisiae. Here, we characterize ddTpp1, a
TPP1 ortholog present in the social amoeba Dictyostelium
discoideum. Lysates from cells lacking ddTpp1 show a reduced but
not abolished ability to cleave a TPP1 substrate, suggesting that
other Dictyostelium enzymes can perform this cleavage. ddTpp1 and
human TPP1 localize to the lysosome in Dictyostelium, indicating
conserved function and trafficking. Cells that lack ddTpp1 show
precocious multicellular development and a reduced ability to form
spores during development. When cultured in autophagy-stimulating
conditions, cells lacking ddTpp1 rapidly decrease in size and are less
viable than wild-type cells, suggesting that one function of ddTpp1
could be to limit autophagy. Cells that lack ddTpp1 exhibit strongly
impaired development in the presence of the lysosome-perturbing
drug chloroquine, and this phenotype can be suppressed through a
secondary mutation in the gene that we name suppressor of tpp1–
A (stpA), which encodes a protein with some similarity to mammalian
oxysterol-binding proteins (OSBPs). Taken together, these results
suggest that targeting specific proteins could be a viable way to
suppress the effects of loss of TPP1 function.
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INTRODUCTION
Neuronal ceroid lipofuscinosis (NCL), or Batten disease, is the most
common childhood-onset neurodegenerative disease, and it is
characterized by a progressive decline in vision, motor skills and
mental ability (Jalanko and Braulke, 2009). The disease is inevitably
fatal, with death generally occurring within a few years of the onset
RESEARCH ARTICLE
Department of  Biology, Texas A&M University, College Station, TX 77843-3474,
USA.
*Author for correspondence (rgomer@tamu.edu)
This is an Open Access article distributed under the terms of  the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted
use, distribution and reproduction in any medium provided that the original work is properly
attributed.
Received 20 October 2014; Accepted 21 December 2014
of symptoms, and there is currently no treatment available. The
occurrence of NCL is one to five per 100,000 births (Zeman, 1974),
with the highest incidence rate among Northern European
populations (Gardiner et al., 1990; Yan et al., 1993), and an
estimated 25,000 families in the United States are affected by NCL
(Zhong et al., 2000). Children with NCL have autofluorescent
bodies within lysosomes in both neurons and in non-neural tissues
(Miley et al., 1978); however, whether these bodies are causative for
the disease or are merely correlative is unclear (Warrier et al., 2013).
In many but not all types of NCL, the primary protein component
of these bodies is mitochondrial ATPase subunit c, which can
constitute up to two-thirds of the mass of the fluorescent bodies
(Palmer et al., 1989). Most types of NCL show an autosomal
recessive pattern of inheritance, and mutations in any of the 14
characterized genes can lead to the development of NCL (Warrier et
al., 2013). Many of the proteins encoded by these genes localize to
and/or function in the lysosome (Palmer et al., 2013). Despite this
lysosomal association, little is known about how mutations in this
set of genes cause the symptoms associated with NCL.
Late infantile neuronal ceroid lipofuscinosis (LINCL), a subclass
of NCL with an onset age of 2 to 4 years (Schulz et al., 2013), is
caused primarily by mutations in the lysosomal peptidase tripeptidyl
peptidase 1, or TPP1 (Sleat et al., 1997). TPP1, also known as
CLN2, cleaves tripeptides from the N-terminus of proteins (Vines
and Warburton, 1998) and shows optimal peptidase activity at pH
3.5 (Sohar et al., 1999). Fibroblasts from individuals with LINCL
show a dramatic reduction in lysosomal TPP1 activity, with 2 to 6%
activity of that of fibroblasts from unaffected individuals (Vines and
Warburton, 1999). Purified TPP1 cleaves peptides corresponding to
the sequences of mitochondrial ATPase subunit c, amyloid β,
angiotensin II and substance P (Junaid et al., 2000), although in vivo
substrates have not been identified. Little is known about the normal
physiological functions of TPP1. TPP1 is highly conserved among
vertebrates (Wlodawer et al., 2003), although TPP1 orthologs have
not been detected in Drosophila, Caenorhabditis elegans or
Saccharomyces cerevisiae, greatly limiting the study of TPP1 in
model organisms.
The social amoeba Dictyostelium discoideum has been utilized to
characterize genes that play a role in neurodegenerative diseases,
such as Huntington’s disease (Myre et al., 2011), Alzheimer’s
disease (Kim et al., 2009) and Parkinson’s disease (van Egmond et
al., 2008). Under conditions where nutrients are abundant,
Dictyostelium exists as a unicellular amoeba that feeds on bacteria
(Kessin, 2001). However, when starved, Dictyostelium cells stop
proliferating and begin secreting relayed pulses of the
chemoattractant cyclic (c)AMP, leading to the aggregation of cells
into groups of approximately 105 cells (Firtel and Meili, 2000).
These groups then undergo a morphogenetic process that produces
a fruiting body structure, which comprises an approximately 2-mm
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stalk supporting a ball of spores, ~24 hours after the onset of
starvation (Loomis, 1982). Despite the considerable evolutionary
distance between Dictyostelium and humans, the tractable genetics
and biochemistry of Dictyostelium have proven useful for the study
of genes that are associated with neurodegenerative diseases
(Annesley et al., 2014). Recently, a report on the Dictyostelium
ortholog of CLN3, another gene that can underlie NCL pathology
when mutated, has revealed that Dictyostelium cells that lack CLN3
show precocious development (Huber et al., 2014), indicating that
CLN3 functions as a negative regulator in Dictyostelium. Expression
of human CLN3 in this mutant rescued this phenotype,
demonstrating that CLN3 is functionally conserved and that the
study of NCL-associated genes in Dictyostelium might help us to
understand the physiological functions of these genes and how
mutations in these genes are linked to NCL pathologies.
Here, we report that ddTpp1, the Dictyostelium ortholog of TPP1,
shows multiple functional similarities with human TPP1. Cells that
lack ddTpp1 (tpp1–) show a reduced but not abolished ability to
cleave the synthetic TPP1 substrate Ala-Ala-Phe-amino-methyl-
coumarin (AAF-AMC). ddTpp1 and human TPP1 localize to the
lysosome when expressed in Dictyostelium, indicating conserved
lysosomal function and trafficking mechanisms. Previous work has
shown that ddTpp1 expression is detectable only during
development (Iranfar et al., 2001). Consistent with this expression
pattern, we find that tpp1– cells resemble wild-type cells during
vegetative growth but show precocious development and a reduced
ability to generate spores during development. Further, starved tpp1–
cells show intracellular autofluorescent bodies that are analogous to
those seen in the cells of individuals that lack TPP1. In response to
amino acid starvation, tpp1– cells show reduced cell size and
viability as compared with wild-type cells, suggesting that
autophagy is aberrant in tpp1– cells. The development of tpp1– cells
is strongly impaired in the presence of the lysosome-perturbing
compound chloroquine, and this phenotype can be suppressed
through a secondary mutation in a gene that we name suppressor of
tpp1– A (stpA), a gene encoding a protein with similarity to
mammalian oxysterol-binding proteins (OSBPs).
RESULTS
The Dictyostelium genome encodes a putative TPP1 ortholog
(ddTpp1) with 37% identity and 52% similarity to the human TPP1
protein, with 100% conservation at catalytic residues (supplementary
material Fig. S1) (Walus et al., 2010). Like human TPP1, ddTpp1
encodes an N-terminal pro-peptidase activation domain and a C-
terminal peptidase domain of the S53 family (Golabek and Kida,
2006; Van de Ven et al., 1993). ddTpp1 is expressed at very low levels
in vegetative cells, but is strongly upregulated during development in
prespore cells (Iranfar et al., 2001), with expression peaking at
16 hours after the initiation of starvation (Parikh et al., 2010). To
characterize ddTpp1, we sought to disrupt the ddTpp1 gene. We used
homologous recombination to generate a ddTpp1 disruption mutant
(tpp1–, see Materials and Methods) in the Ax2 wild-type background
and confirmed disruption of the ddTpp1 gene by using PCR analyses
(supplementary material Fig. S2).
The proteolytic activity of TPP1 can be measured using the
substrate AAF-AMC, which changes fluorescence when the AAF
tripeptide is removed through cleavage (Lin et al., 2001). To test
whether the tpp1– mutant shows reduced proteolytic activity, we
assayed cell lysates from cells that had been starved for 16 hours for
the ability to cleave this substrate. Lysates from tpp1– cells showed
somewhat reduced TPP1 activity as compared with wild-type cell
lysates (Fig. 1). To attempt to rescue the reduced TPP1 activity in
tpp1– cells, we utilized the cotB promoter, which drives gene
expression during development in prespore cells, resembling the
endogenous ddTpp1 expression pattern (Zhang et al., 1999).
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TRANSLATIONAL IMPACT
Clinical issue
Neuronal ceroid lipofuscinosis (NCL) is a childhood-onset
neurodegenerative disease that is inevitably fatal and has no cure. The
disease is caused by genetic mutations in any of 14 characterized
genes, all of which result in a similar class of symptoms, including
progressive decline in vision, motor functions and mental ability. A better
understanding of the function of these genes might guide the
development of therapies. One of these genes, CLN2, encodes the
lysosomal protein tripeptidyl-peptidase 1 (TPP1). Little is known about
the normal physiological function of TPP1, in part because TPP1 is not
present in many commonly used model organisms, such as yeast, fruit
flies or roundworms. However, TPP1 is present in Dictyostelium
discoideum, a well-studied and genetically tractable amoeba.
Results
In this work, the authors characterize ddTpp1, the Dictyostelium ortholog
of TPP1, and show that ddTpp1 has multiple similarities to the human
protein in proteolytic activity and trafficking. Dictyostelium cells that are
mutant for TPP1 (ddTpp1 disruption mutant, tpp1–) are less viable than
wild-type cells under conditions that induce autophagy, suggesting that
TPP1 plays a role in the autophagic process. In addition, the authors find
that a secondary mutation in the gene that they name suppressor of
tpp1– A (stpA), which encodes a protein with similarity to a human protein
involved in sphingolipid metabolism, can suppress a phenotype that is
associated with a lack of ddTpp1, suggesting that perturbing the function
of analogous human suppressor genes might ameliorate some of the
symptoms induced by mutation of TPP1. 
Implications and future directions
This study establishes Dictyostelium as a tractable model system for the
study of NCL caused by mutation of TPP1. Future directions include
utilizing Dictyostelium to better understand the normal physiological roles
of TPP1 and the use of Dictyostelium genetics to identify novel genetic
suppressors of phenotypes caused by loss of TPP1 function. Identifying
such suppressors could guide approaches to the treatment of NCL
pathologies.
Fig. 1. tpp1– cells show reduced proteolytic activity. Cell lysates from
equivalent numbers of 16-hour starved cells were incubated with 50 μM AAF-
AMC, and the fluorescence of the released fluorophore AMC was measured
30 minutes after the addition of substrate. The fluorescence was normalized
to that of wild type for each independent experiment. Values are
means±SEM, n=4. **P<0.01; ns, not significant (one-sample t-test with















Expression of ddTpp1 or human TPP1 in tpp1– cells under control
of the cotB promoter rescued the reduction in TPP1 activity that was
seen in tpp1– cells (Fig. 1). These results indicate that ddTpp1 has
proteolytic activity similar to that of human TPP1. We were unable
to generate a strain in which the entire ddTpp1 open reading frame
was deleted, so we are unable to distinguish whether the TPP1
activity seen in the tpp1– strain was due to other proteins that have
enzymatic activity like that of TPP1, or whether the tpp1– strain
contains a hypomorphic allele with some retention of proteolytic
activity. Regardless, these results indicate that the tpp1– strain
shows, at least, a partial loss of ddTpp1 activity.
TPP1 is a lysosomal protease (Golabek and Kida, 2006). To
examine whether ddTpp1 might also be a lysosomal protein, we
constructed a protein comprising ddTpp1 fused to green fluorescent
protein (ddTpp1-GFP) and examined the subcellular localization of
this fusion protein. ddTpp1-GFP colocalized with the lysosomal
marker Lysotracker (Fig. 2) and was not observed outside of
lysosomes, indicating that ddTpp1 is associated with lysosomes.
Some lysosomes, however, did not appear to contain ddTpp1-GFP.
Human TPP1 also localized to the lysosome in Dictyostelium
(Fig. 2), indicating that the trafficking mechanisms of these two
proteins are conserved.
Having shown that the human and Dictyostelium TPP1 orthologs
exhibit conservation in function and subcellular localization, we next
focused specifically on understanding the physiological roles of
ddTpp1 in Dictyostelium. ddTpp1 is strongly upregulated during
development (Parikh et al., 2010), suggesting that ddTpp1 functions
primarily at this stage. During vegetative growth, tpp1– cells
proliferate like wild-type cells (Fig. 3A), further suggesting that
ddTpp1 functions primarily during development. To assess whether
ddTpp1 affects development, we examined the developmental
timing and morphology of wild-type and tpp1– cells on non-nutrient
agar plates. At 12 hours, wild-type cells had aggregated to form
mounds (Fig. 3B). By contrast, tpp1– cells showed precocious
development, with a mixture of mounds, tipped mounds and
migratory slugs. Expression of ddTpp1 using the cotB promoter
(cotB::ddTpp1) in the tpp1– mutant rescued this precocious
development. At 24 hours, wild-type, tpp1– and tpp1–/
cotB::ddTpp1 cells had differentiated into fruiting bodies that
showed normal morphology (Fig. 3B). These results indicate that
ddTpp1 might play a role in developmental timing, but that ddTpp1
is not required for proper fruiting body morphogenesis.
Because the temporal expression of ddTpp1 suggests a role in the
developmental process, we next tested whether ddTPP1 affects the
number of viable spores that are generated during development by
allowing a fixed number of cells to undergo development, collecting
and counting the generated spores, and then plating spores onto
lawns of bacteria and counting the resultant colonies from spore
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Fig. 2. Dictyostelium and human TPP1 localize to the
lysosome in Dictyostelium cells. Cells were starved for
16 hours in shaking culture, stained with Lysotracker, and
then imaged in chamber slides by confocal microscopy;
images are representative of three independent
experiments. hsTpp1-GFP, human TPP1 fused to GFP.
Scale bar: 10 μm.
Fig. 3. ddTpp1 affects developmental
timing but does not affect
proliferation during vegetative
growth. (A) Cells were inoculated into
HL5 medium at 1×105 cells/ml, and cell
density was determined daily with a
hemocytometer. Values are mean±SEM,
n=3. (B) Cells were spread onto non-
nutrient agar plates and allowed to
develop for the indicated time; images
are representative of three independent
experiments. Scale bars: 1 mm


















germination. tpp1– cells produced significantly fewer visible spores
than wild-type cells during development, and this phenotype could
be rescued through expression of cotB::ddTpp1 in tpp1– cells
(Fig. 4). We then plated equivalent numbers of detergent-treated
spores onto lawns of bacteria and saw that there was no significant
difference in the number of germinated spores when comparing
wild-type, tpp1– and tpp1–/cotB::ddTpp1 cells. These results indicate
that ddTpp1 affects the number of spores generated during
development, but not spore viability.
Intracellular autofluorescent deposits are a hallmark of NCL
(Golabek and Kida, 2006). To examine whether tpp1– cells show
similar accumulations of autofluorescent material, we examined the
autofluorescence of cells by using fluorescence microscopy and
flow cytometry. We allowed cells to undergo aggregation in
chamber slides for 16 hours and then imaged cells at the periphery
of aggregates. tpp1– cells tended to show a more rounded
morphology than wild-type cells and showed a higher degree of
intracellular autofluorescence (Fig. 5A). Cells within the 16-hour
aggregates showed significant levels of autofluorescence for both
wild-type and – genotypes (data not shown). As a parallel approach,
we starved cells for 16 hours in shaking culture and examined the
autofluorescence of cells by using flow cytometry. tpp1– cells were
more autofluorescent than wild-type cells, and this phenotype could
be rescued by expression of cotB::ddTpp1 in the tpp1– background
(Fig. 5B). Wild-type and tpp1– cells that had been collected from
vegetative growth conditions on bacterial lawns showed similar
levels of autofluorescence (Fig. 5C), indicating that the difference
in autofluorescence was specific to the developmental phase. These
results indicate that, as in humans, loss of TPP1 activity in
Dictyostelium results in the accumulation of autofluorescent bodies
within cells, although whether this autofluorescence derives from
the same molecules in Dictyostelium as in individuals with NCL is
currently unclear.
The fact that tpp1– cells show a deficiency in spore production
during development indicates that the lysosomal protease ddTpp1
has some fitness-increasing function during development.
Autophagy, the catabolism of sequestered cellular components via
lysosomal fusion (Klionsky and Emr, 2000), is required for proper
development in Dictyostelium (Otto et al., 2003). Autophagy can be
stimulated in Dictyostelium by culturing cells in axenic autophagy-
stimulating media (ASM) without the essential amino acids arginine
and lysine, which results in a progressive reduction in cell size and
protein content due to catabolism (King et al., 2011). In contrast to
wild type, mutants defective in autophagy do not show a significant
reduction in size in ASM (King et al., 2013). Further, autophagy-
defective mutants show a marked reduction in protein turnover in
autophagy-stimulating conditions as compared to wild type and are
less viable than wild type when cultured in ASM, suggesting a loss
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Fig. 4. Tpp1 affects the development
of spores. (A) Ten million cells were
allowed to develop on filter pads for
24 hours, and then spores were
collected and counted. (B) Equivalent
numbers of the collected spores were
treated with detergent and plated onto a
lawn of K. aerogenes bacteria, and the
number of resultant colonies was
counted. Values are means±SEM, n=4.
*P<0.05 (one-way ANOVA, Tukey’s
test).
Fig. 5. tpp1– cells show increased intracellular
autofluorescent material. (A) Cells were starved
for 16 hours in chamber slides, and intracellular
autofluorescent material in cells at the periphery of
cell aggregates was imaged by using confocal
microscopy; images are representative of three
independent experiments. Scale bar: 20 μm.
(B) Cells were starved in shaking culture for
16 hours, and the cellular autofluorescence was
assayed by using flow cytometry. The average
fluorescence per cell was normalized to that of
wild type. Values are means±SEM, n=3. *P<0.05;
ns, indicates not significant (one-sample t-test with
comparison to the value 100%). (C) Cells growing
on a bacterial lawn were collected and assayed as
described in B. Values are means±SEM, n=3. The
differences between wild-type and either tpp1– or
tpp1–/cotB::ddTpp1 are not significant (one-sample
















in viability due to an inability to generate nutrients through
catabolism (King et al., 2013). To test whether ddTpp1 affects the
autophagic response of cells, we cultured cells in ASM and
measured cell size and cell viability as a function of time. Wild-type
and tpp1– cells showed a similar initial size and decreased in size
during concomitant arginine and lysine starvation, indicating that
tpp1– cells are capable of an autophagic response (Fig. 6A).
However, tpp1– cells were significantly smaller than wild-type cells
when continuously cultured in ASM (Fig. 6A,C). Further, tpp1– cells
were less viable after culture in ASM, as assayed by the ability to
form colonies on bacterial lawns (Fig. 6B). Both the cell size and
cell viability phenotypes of tpp1– cells in ASM were rescued by
expression of cotB::ddTpp1 in Tpp1 cells (Fig. 6), indicating that
these phenotypes are due specifically to a deficiency of ddTpp1, and
suggesting that developmentally regulated promoters are active
under these conditions. Taken together, these results indicate that
ddTpp1 is required for a proper autophagic response during amino
acid starvation.
Identifying second-site mutations that suppress the phenotypes of
tpp1– cells could guide approaches to reducing or preventing
pathologies that arise from the loss of TPP1 activity in humans. We
thus sought to identify phenotypes that we could utilize in a tractable
screen for second-site suppressor mutations. As the tpp1– mutant
shows some tripeptidyl-peptidase activity, but less activity than wild
type (Fig. 1), we reasoned that if some compound caused a
developmental defect by affecting tripeptidyl-peptidase activity, the
tpp1– mutant should be more sensitive to such an effect than the
wild type. While examining the effects of various compounds on
wild type and tpp1– development, we saw that the drug chloroquine
strongly impaired the development of tpp1– cells that were growing
as colonies on a bacterial lawn (Fig. 7A). By contrast, the effects of
chloroquine on the development of wild type were much less severe
(Fig. 7A). Intriguingly, chloroquine, a weak base, is a well-
characterized lysosomal inhibitor that accumulates in lysosomes due
to protonation at low pH (Seglen et al., 1979) and that affects the
regulation of autophagic flux (Li et al., 2013). We further tested the
effect of chloroquine on development by examining the aggregation
of cells in submerged culture and found that tpp1– cells aggregated
more slowly than wild-type cells in the presence of chloroquine
(Fig. 7B). Ammonium chloride, another weak base that inhibits
lysosomal function (Amenta and Brocher, 1980), also slowed
aggregation and had a stronger effect on tpp1– cells than on wild-
type cells (Fig. 7B). These results indicate that the loss of ddTpp1
results in a hypersensitivity to the effects of chloroquine and
ammonium chloride.
To identify second-site mutations that suppress the tpp1–
developmental phenotype in the presence of chloroquine, we
mutagenized cells using restriction enzyme-mediated integration
(REMI) mutagenesis (Kuspa, 2006) and examined the development
of mutant clones in the presence of chloroquine. Because REMI
mutagenesis requires a parental strain that is sensitive to blasticidin,
we generated a new strain, tpp1flox–, in which a blasticidin cassette
had been inserted into the ddTpp1 gene and then removed from the
genome by using Cre-mediated recombination (Faix et al., 2004),
generating a blasticidin-sensitive strain in which multiple in-frame
stop codons are present within the ddTpp1 N-terminal domain
(supplementary material Fig. S3). Like tpp1– cells, tpp1flox– cells
showed aberrant development in the presence of chloroquine
(Fig. 8A). We generated 30,000 REMI mutants in the tpp1flox–
background and examined the development of individual clones
growing as colonies in the presence of chloroquine. We observed
that one clone, which we named stpA (for suppressor of tpp1– A),
was able to form fruiting bodies under conditions where chloroquine
was present, whereas the parental tpp1flox– strain did not show
fruiting body development (Fig. 8A).
We used inverse PCR analyses (Keim et al., 2004) to identify the
genetic lesion in the stpA REMI strain, and we determined that the
insertion was located within the coding region of the gene
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Fig. 6. Tpp1 affects the autophagic
response of cells. (A) The size of cells
cultured continuously in autophagy-
stimulating media (ASM) was measured
daily by flow cytometry using forward scatter.
Values are means±SEM, n=5. * indicates
that differences between wild type and tpp1–
were significant with P<0.05, **P<0.01 and
***P<0.001 (one-way ANOVA, Tukey’s test).
Differences between wild type and
tpp1–/cotB::ddTpp1 were not significant for
any time point. (B) Every 2 days, an aliquot
was taken from a culture of cells continually
cultured in ASM and then spread onto a
lawn of K. aerogenes bacteria, and the
viability of cells was measured by counting
the resulting colonies. Values are
means±SEM, n=4. * indicates that
differences between wild type and tpp1–
were significant with P<0.05 (one-way
matched values ANOVA, Tukey’s test).
Differences between wild type and
tpp1–/cotB::ddTpp1 were not significant for
any time point. (C) Cells cultured for 8 days
in ASM were allowed to settle in a glass
chamber slide, and then cells were imaged
with an inverted phase-contrast microscope;
images are representative of three

















DDB_G0282973 (we subsequently refer to this gene as stpA).
Although not a clear ortholog, StpA shows significant similarity to
members of the OSBP family (supplementary material Fig. S4),
which function in both the transcriptional regulation of lipid
biosynthetic genes and the trafficking of lipids, such as sterols and
sphingolipids (Olkkonen and Li, 2013). To test whether the
suppression of the tpp1– phenotype is due specifically to the loss of
stpA function, we constructed a double mutant strain,
tpp1flox–/stpA–, in which the entire stpA open reading frame had
been deleted by using homologous recombination. We confirmed the
knockout of the entire stpA gene in the tpp1flox– genetic background
by using PCR analyses (supplementary material Fig. S5).
tpp1flox–/stpA– cells formed morphologically normal fruiting bodies
under standard conditions (Fig. 8B, compare with Fig. 3B).
Strikingly, and in contrast to tpp1flox– cells, tpp1flox–/stpA– cells did
not show a delay in aggregation as compared with the wild type
when starved in the presence of ammonium chloride (Fig. 8C).
Further, whereas tpp1flox– cells showed delayed development in 
the presence of chloroquine, tpp1flox–/stpA– cells showed
development similar to that of wild-type cells under these conditions
(Fig. 8D). These results strongly suggest that loss of stpA function
can suppress the hypersensitivity of tpp1– cells to chloroquine and
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Fig. 7. Development of tpp1– cells is
inhibited in the presence of chloroquine
or ammonium chloride. (A) Clonal cell
colonies were grown on SM/5 plates
supplemented with 3 mM chloroquine and
then spread with a lawn of K. aerogenes
bacteria; images were taken after 8 days
and are representative of three
independent experiments. (B) Cells were
starved in a 24-well plate for 14 hours in
PBM (for PBM buffer components, see
Materials and Methods), PBM with 5 mM
chloroquine, or PBM with 20 mM
ammonium chloride. All images are
representative of three independent
experiments. Scale bars: 1 mm (A);
200 μm (B).
Fig. 8. Loss of StpA suppresses the 
slow development phenotype of
tpp1floxed– cells in the presence of
chloroquine or ammonium chloride.
(A) Clonal cell colonies were grown on
SM/5 plates supplemented with 3 mM
chloroquine spread with a lawn of K.
aerogenes bacteria; images were taken
after 8 days. (B) tpp1floxed–/stpA–
development at 24 hours was examined as
described in Fig. 3. (C) Cells were starved
for 14 hours in a 384-well plate in PBM
containing 20 mM ammonium chloride.
(D) Development in the presence of
chloroquine was examined as described in
A. All images are representative of three
independent experiments. Scale bars:

















ammonium chloride during development. We then tested whether
loss of stpA suppressed other phenotypes of tpp1– cells. In tpp1–
cells, loss of stpA did not suppress the reduced cell size and viability
of tpp1– cells under autophagic conditions, the precocious
development of tpp1– at 12 hours, or the increased autofluorescence
seen in tpp1– cells (data not shown). These results indicate that loss
of stpA function can suppress some but not all of the phenotypes of
tpp1– cells.
DISCUSSION
Although mutations in the human protein TPP1/CLN2 underlie one
of the NCL disorders, little is known about the physiological
functions of this protein or how the loss of TPP1 function causes the
symptoms associated with the disease. Here, we have shown that
ddTpp1, an ortholog of TPP1, has multiple functional similarities to
its human counterpart. Further, we identify a second-site suppressor
mutation that suppresses some but not all of the phenotypes of tpp1–
cells, suggesting that the perturbation of second-site gene products
could provide a therapeutic approach for NCL. Our work establishes
Dictyostelium as a tractable system for the study of TPP1, which is
absent in many traditional model organisms, such as S. cerevisiae,
Drosophila, and C. elegans.
Although previous studies of TPP1 loss of function in other
organisms have shown complete ablation of TPP1 peptidase activity,
as measured by the degradation of a substrate in vitro (Awano et al.,
2006; Mahmood et al., 2013; Passini et al., 2006; Walus et al.,
2010), we saw that tpp1– cells retained a significant amount of
activity in this in vitro assay. Although we cannot rule out that our
mutant is a hypomorph, we suspect that this residual TPP1 activity
is due to a separate peptidase. In fact, a protein with TPP1 activity
has been previously purified from Dictyostelium cell lysates
(Krimper and Jones, 1999), although this purified protein showed a
monomeric mass of 107 kDa, whereas mature ddTpp1 has a
predicted mass of 42 kDa, suggesting that this purified protein was
not ddTpp1. Further, the purified protein activity is most abundant
at the vegetative life-cycle stage (Krimper and Jones, 1999),
whereas ddTpp1 shows no detectable expression during the
vegetative stage (Iranfar et al., 2001). The optimal pH for the
activity of the purified peptidase is 4.5 (Krimper and Jones, 1999),
suggesting that the peptidase is lysosomal. An exciting possibility is
that an ortholog of this unidentified peptidase is present in humans
but is not widely expressed and that therapeutic approaches that
could upregulate this unidentified protease might serve to restore
TPP1 activity. Thus, the identity of this peptidase is of considerable
interest.
Consistent with the previously reported low expression of ddTpp1
in vegetative cells but high expression during development (Iranfar
et al., 2001), we find that vegetative tpp1– cells show no obvious
phenotype, whereas starving or developing tpp1– cells show
substantial differences to wild-type cells. There are two possible
explanations for why a lysosomal peptidase might be upregulated
during starvation or development. First, starving or developing cells
show little or no proliferation and generate cellular energy by using
autophagy (Calvo-Garrido et al., 2010), and are thus in a position
where they are generating potentially toxic catabolic byproducts
while not being able to dilute these byproducts through continued
proliferation. Thus, the expression of additional catabolic enzymes,
such as ddTpp1, during development or starvation could be required
to prevent the buildup of products of catabolism in non-proliferating
cells, and this might explain why starved tpp1– cells produce
abnormally few spores. Interestingly, an analogous phenomenon
occurs in cultured mouse cerebellum cells lacking the NCL-linked
protein CLN3, where non-proliferating, confluent immortalized
granule neurons that lack functional CLN3 show subcellular
deposits of mitochondrial ATP synthase subunit c and
autofluorescent material, whereas proliferating, sub-confluent cells
of the same type do not show these hallmarks of NCL (Fossale et
al., 2004). Furthermore, peptidases that are expressed during
development might function in developmental signaling by acting
on developmental signaling molecules or extracellular structural
proteins (Fong and Bonner, 1979). We saw that tpp1– cells showed
precocious development, suggesting that ddTpp1 might in fact
function in the negative regulation of development. Intriguingly,
Dictyostelium cells lacking the ortholog of CLN3, another gene that
can cause NCL when mutated, also showed precocious development
at the mound stage (Huber et al., 2014). It could be the case that in
Dictyostelium, NCL-associated genes play a significant role in
developmental timing. Investigation of other NCL genes [the
Dictyostelium genome encodes orthologs of CLN1-5, CLN7 and
CLN10-14 (Huber et al., 2014)] will reveal the extent of this
functional overlap. One possibility is that NCL-linked genes might
affect the activity of the protein kinase A (PKA) pathway, which is
crucial for proper developmental timing (Loomis, 1998).
We found that the loss of ddTpp1 affected cell size and survival
under autophagy-stimulating conditions, suggesting that ddTpp1
affects the autophagic response. Cells that are unable to undergo
autophagy do not show a significant reduction in size during
autophagic conditions, but they do show reduced viability during
autophagic conditions, suggesting that aberrant autophagy can cause
a loss in viability due to an inability to generate nutrients through
catabolism (King et al., 2013). tpp1– cells do show a reduction in
size in autophagy-stimulating conditions, indicating that autophagy
is not abolished but is aberrant in these cells. The abnormally rapid
reduction in cell size and cell viability of tpp1– cells under
autophagy-stimulating conditions indicates the possibility that the
tpp1– cells have enhanced autophagy, and thus that one function of
ddTpp1 might be to limit autophagy. Autophagy has previously been
shown to be aberrant in NCL – mice mutant for CLN3 show an
increase in the autophagic marker LC3 in brain tissue (Cao et al.,
2006), and CLN2 mutant human fibroblasts under autophagic
conditions show significantly higher levels of reactive oxygen
species than wild-type cells (Vidal-Donet et al., 2013). Future
studies in Dictyostelium might help to reveal the role of autophagy
in the reduced viability of cells that lack TPP1.
The development of tpp1– cells is strongly inhibited by chloroquine,
and this phenotype is suppressed by a secondary mutation in StpA, a
protein with similarity to mammalian OSBPs. OSBPs function in the
subcellular trafficking of lipids, and the regulation of sterol and
sphingolipid metabolism (Olkkonen and Li, 2013). Intriguingly, many
NCL genes have been linked to sphingolipid metabolism (Granier et
al., 2000; Haltia et al., 1995; Persaud-Sawin et al., 2004; Persaud-
Sawin et al., 2007), and cerebral samples from individuals with
mutations in the CLN8 gene show reduced levels of the sphingolipid
ceramide (Hermansson et al., 2005). An exciting possibility is that the
modulation of sphingolipid metabolism by targeting sphingolipid
regulators, such as OSBPs, might be a way of controlling the
pathogenic effects of NCL.
Dictyostelium has proven to be a useful system for studying
proteins that are associated with lysosomal (Maniak, 2011) and
neurodegenerative diseases (Annesley et al., 2014; Myre et al.,
2011). We have demonstrated that the Dictyostelium ortholog of
TPP1 shows multiple functional parallels with the human protein
and that the genetic tools available in Dictyostelium can be used to
find genetic suppressors of phenotypes that are caused by loss of
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ddTpp1 function. Future studies in Dictyostelium might reveal
additional genes that are functionally linked with ddTpp1 and will
provide a better understanding of the physiological functions of
TPP1, which is crucial for developing future therapies for NCL.
MATERIALS AND METHODS
Cell culture and strain construction
Cells were maintained in axenic shaking culture in HL5 medium (Formedium
Ltd, Norwich, UK) at 20°C. All strains described in this study are derived
from the Ax-2 strain. Dictyostelium transformations were performed following
standard protocols (Gaudet et al., 2007). Examination of development on agar
plates was performed as described previously (Tang and Gomer, 2008).
Proliferation curves were generated as described previously (Brock and
Gomer, 2005), except that cells were inoculated at 1×105 cells/ml. Spore
viability assays were performed as described previously (Phillips and Gomer,
2010). For each independent experiment, spores for each genotype were
collected from fruiting bodies of the same age.
Previously, the ddTpp1 gene had been disrupted by using REMI
mutagenesis at genomic position Chr1:3853302, resulting in the insertion of
a blasticidin-resistance cassette and multiple in-frame stop codons within the
sequence encoding the N-terminal pro-peptidase activation domain of
ddTpp1. A plasmid containing this cassette and flanking genomic arms from
the insertion site had been previously cloned into bacteria by using plasmid
rescue (the isolated plasmid was a gift from Chris Dinh and Adam Kuspa,
Baylor College of Medicine, Houston, Texas), allowing recreation of this
mutation by using homologous recombination. To generate a ddTpp1
disruption mutant, the ddTpp1 REMI vector was linearized using EcoRI
digestion and was then transformed into wild-type cells. To confirm
disruption of the ddTpp1 locus, we used PCR to show the absence of an
intact locus using the genomic primers 5ʹ-TCACGATCCAAGTGGGTACA-
3ʹ and 5ʹ-GGCGATTTCATTCGTACCAT-3ʹ, and the presence of the REMI
insertion at the ddTpp1 locus using the primers 5ʹ-GAGTTGGAAG -
ATTTCGTGTG-3ʹ and 5ʹ-ATTTAGGTGACACTATAG-3ʹ (supplementary
material Fig. S2).
To generate a ddTpp1 rescue strain expressing Tpp1 under control of the
cotB promoter, we used the plasmid pVSC (Zhang et al., 1999), a gift from
Chris West (University of Oklahoma College of Medicine, Oklahoma City,
OK, USA). The ddTpp1 open reading frame, excluding the stop codon, was
amplified from genomic Dictyostelium DNA (ddTpp1 has no introns) using
the primers 5ʹ-GGGTACCATGAATATTAAATTTAA TTTAATAATTATAA-
3ʹ and 5ʹ-GAGATCTTTCAAGACAATATTTAA CCAATTC-3ʹ, which
generated KpnI and BglII sites at the start and terminus of the open reading
frame, respectively. This PCR fragment was then digested with KpnI and
BglII and cloned into pVSC, and the resulting plasmid, pJP105, was
transformed into tpp1– cells. To express human TPP1 in Dictyostelium, the
human TPP1 open reading frame lacking the terminal stop codon was
amplified by using PCR of cloned human TPP1 cDNA (a kind gift from
Peter Lobel, Rutgers University, Highland Park, NJ, USA) using the primers
5ʹ-GGGTACCATGGGACTCCAAGCCTGC-3ʹ and 5ʹ-GAGATCTGGGGT -
TGAGTAGAGTCTTCAGC-3ʹ, which generate KpnI and BglII sites at the
start and terminus of the open reading frame, respectively. This PCR product
was cloned into pVSC and the resulting plasmid pJP106 was transformed
into tpp1– cells. To generate cells expressing ddTpp1-GFP, the ddTpp1 open
reading frame lacking the stop codon was amplified from genomic DNA by
PCR with the primers 5ʹ-GGAGATCTATGGGACTCCAA GCCTGC-3ʹ and
5ʹ-GGACTAGTGGGGTTGAGTAGAGTCTTCAGC-3ʹ, which add BglII
and SpeI sites to the ddTPP1 start and terminus, respectively. The PCR
product was digested with BglII and SpeI and then ligated into the vector
pDM323 (Veltman et al., 2009), generating an open reading frame encoding
ddTpp1 with a C-terminal GFP fusion. The resulting plasmid pJP107 was
then transformed into tpp1– cells. To generate Dictyostelium cells expressing
human TPP1-GFP, an identical strategy was used, except that human TPP1
was amplified from cloned cDNA using the primers 5ʹ-GGAGATCT -
ATGGGACTCCAAGCCTGC-3ʹ and 5ʹ-GGAC TAGTGGGGTTGAGTAG -
AGTCTTCAGC-3ʹ.
To generate a ddTpp1 disruption vector in which LoxP sites flank the
blasticidin resistance cassette, we cloned the homologous arms from the
ddTpp1 REMI vector into the vector pLPBLP (Faix et al., 2004). The
primers 5ʹ-GGGGTACCACCATTATTGTCACCCAGACC-3ʹ and 5ʹ-
GGAAGCTTATAAAGTTCTCTTGGAATAGTGTAAGG-3ʹ were used to
amplify the homologous arms and the connecting EcoRI site, generating a
DNA fragment with the following components: KpnI site – Homologous
arm 1 – EcoRI site – Homologous arm 2 – HindIII site. This fragment was
digested with KpnI and HindIII and cloned into the KpnI and HindIII sites
of pLPBLP. The generated vector pJP108 was then digested with EcoRI,
yielding a single DNA fragment flanked by arms homologous to the tpp1
locus, and transformed into Ax2 cells. To confirm disruption of the ddTpp1
gene, we tested the absence of an intact ddTpp1 gene with the genomic PCR
primers 5ʹ-GAGTTGGAAGATTTCGTGTG-3ʹ and 5ʹ-TCACGATCCA -
AGTGGGTACA-3ʹ, and the presence of the insert at the ddTpp1 locus with
the PCR primers 5ʹ-GAGTTGGAAGATTTCGTGTG-3ʹ and 5ʹ-AGCA -
TTGTAATCTTCTCTGTCG-3ʹ. To generate the blasticidin-sensitive strain
tpp1flox–, the blasticidin-resistance cassette was removed by using Cre-
mediated recombination (Linkner et al., 2012). To confirm blasticidin
cassette removal, we tested blasticidin-sensitive clones using the genomic
PCR primers 5ʹ-GGCGATTTCATTCGTACCAT-3ʹ and 5ʹ-TCACGATC -
CAAGTGGGTACA-3ʹ, and confirmed that the product was the size
expected for successful excision of the blasticidin S resistance gene (BSR)
by using recombination (supplementary material Fig. S3).
To generate a tpp1flox–/stpA– strain, homologous arms flanking the entire
StpA (DDB_G0282973) open reading frame were amplified by using PCR
from genomic DNA using the primer pairs 5ʹ-GGGGTACCAT -
CACCACAACCATCAAATGC-3ʹ, 5ʹ-GGAAGCTTAATAAATGCAAATT -
AATTACTGATGG-3ʹ and 5ʹ-CCGGATCCTTATATTGTATAATTGGTTC -
ACTTTACC-3ʹ, 5ʹ-GGACTAGTCCCCCTATAAGTTCTAAATAAACAG-
3ʹ. These primers incorporate terminal restriction sites for KpnI, HindIII,
BamHI and SpeI, respectively. These PCR products were cloned into the
vector pLPBLP, generating the plasmid pStpA-KO. pStpA-KO was digested
with KpnI and SpeI and transformed into tpp1flox– cells. To confirm
disruption of the StpA gene, we used the genomic primers 5ʹ-TGCT -
GCTGGTACTAGAACTTCG-3ʹ and 5ʹ-TTTTTCTGCATATTTGTGTGG-
3ʹ to show the lack of an intact StpA gene, and the primers 5ʹ-TGCT -
GCTGGTACTAGAACTTCG-3ʹ and 5ʹ-CACTCGAATACTTCTATCTA -
CTTCGTC-3ʹ to show that the blasticidin-resistance cassette had replaced
the StpA open reading fame (supplementary material Fig. S5).
Tpp1 enzymatic assays
To measure Tpp1 activity in cell lysates, 3 ml of cells at 5×106 cells/ml were
starved for 16 hours in PBM buffer (20 mM KH2PO4, 0.01 mM CaCl2,
1 mM MgCl2, pH 6.1 with KOH). Cells were then counted, resuspended at
7.5×106 cells/ml in 0.05 M MES pH 6.5 with 0.1% NP-40, and lysed by
passage through a Cameo 5 μm nylon filter (Spectrum, New Brunswick, NJ,
USA) using a 1 ml syringe. A solution of 100 μM TPP1 substrate AAF-
AMC HCL (Bachem) was made in 100 mM sodium acetate pH 3.8, and
50 μl of cell lysate (or, as a control, 50 μl of buffer) was mixed with 50 μl
of AAP-AMC solution in a 96-well opaque plate (Nunc) to give a final
concentration of 50 μM Ala-Ala-Phe-AMC. Plates were then incubated at
room temperature for 30 minutes in the dark, and the fluorescence of the
released amino methyl coumarin (AMC) was measured using a Synergy MX
microplate reader (Biotek) using excitation at 360 nm and emission at 440
nm. The fluorescence value for the buffer control condition was subtracted
from the fluorescence values for the experimental samples, and then values
were normalized to the wild-type condition for each independent
experiment.
Microscopy and fluorescence
To examine Tpp1-GFP localization, cells at 2×106 cells/ml in PBM were
starved in shaking culture for 14 hours, and then cells were collected by
centrifugation and resuspended in PBM containing 500 nM Lysotracker Red
(Invitrogen), and incubated in shaking culture for 2 hours. Cells (50 μl) were
then allowed to settle in a well of an 8-well glass chamber slide (Nunc) for
20 minutes, and the medium was removed and replaced with 200 μl PBM.
Cells were then imaged by using an Olympus FV1000 confocal microscope.
To examine the autofluorescence of cells by microscopy, cells growing in
shaking culture in HL5 medium were resuspended in PBM at 1×106 cells/ml,
















and then 200 μl of the cell suspension was allowed to settle in one well of an
8-well glass-bottomed chamber slide (Nunc). Cells were incubated at 20°C for
16 hours, and then the autofluorescence of live cells at the periphery of cell
aggregates was imaged by using an Olympus FV1000 confocal microscope
with excitation with a 543-nm laser and detection of fluorescence at 555-655
nm. To measure cellular autofluorescence by using flow cytometry, cells
growing in shaking culture in HL5 medium were resuspended in PBM at
1×106 cells/ml, and were incubated for 16 hours at 20°C on a rotary shaker.
Cells were then vortexed and analyzed by using flow cytometry with a C6
flow cytometer (Accuri) using a 488-nm excitation laser and a 670-nm LP
(FL-3) filter to detect autofluorescence. For each independent experiment, the
mean autofluorescence of the population was calculated and normalized to the
wild-type value. To examine the autofluorescence of vegetative cells by using
flow cytometry, 1×103 cells were mixed with K. aerogenes bacteria and plated
onto SM/5 plates. After 48 hours at 20°C, Dictyostelium cells and bacteria
were washed from the plate and suspended in 10 ml PBM, and cells were
washed twice by pelleting at 500 g and resuspending in 10 ml PBM to remove
most of the bacteria. An aliquot of the cell suspension was then analyzed for
autofluorescence by flow cytometry as described above, with any remaining
bacteria excluded from the analysis by gating based on forward scatter.
Cell size and viability in media lacking arginine and lysine
Log-phase cells growing in HL5 medium in shaking culture were washed
twice in SIH medium lacking arginine and lysine (ASM medium) (Formedium
Ltd, Norwich, UK) and then resuspended to 5×106 cells/ml in 5 ml ASM. An
aliquot of cells was taken from the culture daily for flow cytometry analysis
using an Accuri C6 flow cytometer, and the average forward scatter of the cell
population was measured. To convert forward scatter measurements into
microns, we measured the forward scatter of beads with diameters of 3.27,
5.05 and 10.1 microns (Spherotech), generated a best-fit curve, and used the
corresponding equation to convert the forward scatter values to diameter in
microns. To assay viability, an aliquot of cells from a culture started at 5×106
cells/ml in 5 ml of ASM was taken every 2 days, and serial dilutions were
plated with K. aerogenes bacteria onto SM/5 plates. Counts of the resultant
colonies were used to calculate the percent cell survival of the culture by
dividing the observed colony count by the theoretical predicted colony count
if cell density had not changed since inoculation and if every cell from the
original inoculation had generated a colony.
Development and aggregation in the presence of chloroquine or
ammonium chloride
To examine development in the presence of chloroquine, SM/5 agar was
prepared, and chloroquine (Sigma-Aldrich) was added to a final
concentration of 3 mM 30 minutes after autoclaving, while the agar was still
molten. SM/5 containing 3 mM chloroquine was then poured into Petri
plates in 24-ml volumes. Serial dilutions of cells were spread with K.
aerogenes onto the chloroquine-containing plates. After 8 days, well-spaced
colonies were imaged either from overhead using a camera stand with side
illumination or with an inverted microscope equipped with a 2× objective,
allowing for imaging through the agar. To examine aggregation in
submerged culture, log-phase cells growing in HL5 medium in shaking
culture were washed in PBM and then resuspended at 1×106 cells/ml in
PBM, PBM with 5 mM chloroquine, or PBM with 20 mM ammonium
chloride. Cells were then pipetted into either 24-well plates in 1-ml volumes
or 384-well plates in 57-μl volumes. After a 14-hour room temperature
incubation, cells were imaged using an inverted microscope.
REMI mutagenesis
REMI mutagenesis was performed using the plasmid pBSR1 as described
previously (Kuspa, 2006). Inverse PCR was performed as described
previously (Keim et al., 2004). To screen for suppressor mutations of the
tpp1flox– phenotype, tpp1flox– cells were mutagenized, and pools of REMI
mutants were plated onto plates containing SM/5 with 3 mM chloroquine,
as described above. Wild-type and tpp1flox– cells were plated in parallel as
controls. REMI mutant clones that showed more rapid fruiting body
development as compared with the parental strain were selected for further
analysis.
Statistics and alignments
Statistical analyses were performed using Prism (GraphPad Software).
Significance was defined as P<0.05. To generate alignments, sequences
were aligned using the CLUSTALW algorithm (Thompson et al., 1994), and
the alignments were formatted using the program BOXSHADE (written by
K. Hoffman and M. Baron).
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